DBV Technologies (DBVT) Total Liabilities (2015 - 2026)

DBV Technologies (DBVT) posted quarterly Total Liabilities of $62.8 million for Q2 2026, up 9.78% year-on-year from $57.2 million in Q2 2025, and up 7.53% on a QoQ basis from $58.4 million in Q1 2026.

DBV Technologies (DBVT) Total Liabilities (2015 - 2026) Analysis & Trends

DBV Technologies (DBVT) has reported Total Liabilities for 12 consecutive years, with $62.8 million the latest figure, recorded in Q2 2026.

  • Quarterly Total Liabilities rose 9.78% year-over-year to $62.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $62.8 million (up 9.78% YoY) and the FY2025 annual result came in at $64.9 million, up 69.58% from the prior year.
  • Total Liabilities grew to $62.8 million in Q2 2026 per DBVT's latest filing, from $58.4 million in the prior quarter.
  • Over the last five years, Total Liabilities for DBVT reached as high as $64.9 million in Q4 2025 and fell as low as $34.2 million in Q1 2024.
  • A 5-year average of $47.5 million and a median of $46.7 million in 2023 frame the typical range for Total Liabilities.
  • Annual changes were most pronounced in 2024 — Total Liabilities plunged 36.4% — and 2025, when it surged 69.58%.
  • Year by year, Total Liabilities stood at $52.1 million in 2022, then retreated by 17.8% to $42.8 million in 2023, then declined by 10.58% to $38.3 million in 2024, then soared by 69.58% to $64.9 million in 2025, then fell by 3.24% to $62.8 million in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods registered $62.8 million, $58.4 million, and $64.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 60.46 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 177.22 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 3.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - 7.33 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 7.12 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 9.45 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 15.48 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.62 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 753.82 Mn
10 DBV Technologies 267.50 Mn 92.60 Mn - 62.80 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 62.80 Mn
Mar 31, 2026 58.40 Mn
Dec 31, 2025 64.90 Mn
Sep 30, 2025 57.64 Mn
Jun 30, 2025 57.21 Mn
Mar 31, 2025 47.69 Mn
Dec 31, 2024 38.27 Mn
Sep 30, 2024 39.02 Mn
Jun 30, 2024 35.10 Mn
Mar 31, 2024 34.24 Mn
Dec 31, 2023 42.80 Mn
Sep 30, 2023 45.79 Mn
Jun 30, 2023 53.28 Mn
Mar 31, 2023 53.83 Mn
Dec 31, 2022 52.06 Mn
Sep 30, 2022 36.07 Mn
Jun 30, 2022 40.56 Mn
Mar 31, 2022 35.52 Mn
Dec 31, 2021 47.45 Mn
Sep 30, 2021 54.03 Mn